BioSpace News Archive

The demand within the global washable and reusable masks market is growing at a sturdy pace in recent years.

PureTech Health plc, a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, announced that George Farmer, Ph.D., has been appointed Chief Financial Officer.

IRRAS AB announced that Kleanthis G. Xanthopoulos, Ph.D., the company’s Chief Executive Officer, and Will Martin, the company’s President and Chief Commercial Officer, will provide a company overview and commercial update at the H.C. Wainwright Virtual BioConnect Conference that will be held January 11 - 14, 2021.

ANGLE plc and, a world-leading liquid biopsy company, announces that it has received notices from “leaver” employees to exercise options over 43,334 Ordinary shares of £0.10 each in the Company.

MiNA Therapeutics, the pioneer in RNA activation therapeutics, announced the appointment of Robin Wright as Chief Financial Officer, effective January 04, 2021.

OraSure Technologies, Inc., a leader in point of care diagnostic tests and specimen collection devices, and microbiome laboratory and analytical services, announced that Dr. Stephen S. Tang, President and CEO, will speak to the investment community at the 39th Annual J.P. Morgan Healthcare Conference.

First-of-its-kind program combines early risk assessment of kidney decline and comprehensive care management to help slow kidney disease progression, improve care coordination and reduce costs

Theravance Biopharma, Inc., a diversified biopharmaceutical company primarily focused on the discovery, development, and commercialization of organ-selective medicines, will webcast its presentation at the 39th Annual J.P. Morgan Healthcare Conference on Wednesday, January 13, 2021, at 2:00 p.m. ET.

Series A financing co-led by Nextech and Vida Ventures with participation from Two River Group, Bellco Capital, Polaris Partners, GV, Wellington Partners and Logos Capital

Generation Bio Co., an innovative genetic medicines company creating a new class of non-viral gene therapy, announced that the company will present at the virtual 39th Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 12, 2021.